97 related articles for article (PubMed ID: 24018603)
1. GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice.
Shen S; Klamer G; Xu N; O'Brien TA; Dolnikov A
Exp Hematol; 2013 Dec; 41(12):1016-27.e1. PubMed ID: 24018603
[TBL] [Abstract][Full Text] [Related]
2. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice.
Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A
Stem Cells Dev; 2015 Mar; 24(6):724-36. PubMed ID: 25329250
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
[TBL] [Abstract][Full Text] [Related]
5. GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells.
Dolnikov A; Xu N; Shen S; Song E; Holmes T; Klamer G; O'Brien TA
Cell Prolif; 2014 Apr; 47(2):113-23. PubMed ID: 24517125
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSK-3β enhances neural differentiation in unrestricted somatic stem cells.
Dastjerdi FV; Zeynali B; Tafreshi AP; Shahraz A; Chavoshi MS; Najafabadi IK; Vardanjani MM; Atashi A; Soleimani M
Cell Biol Int; 2012 Nov; 36(11):967-72. PubMed ID: 22775567
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
8. GSK3 inhibition prevents lethal GVHD in mice.
Klamer G; Shen S; Song E; Rice AM; Knight R; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2013 Jan; 41(1):39-55.e10. PubMed ID: 22999867
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cells.
Jiang J; Zhao M; Zhang A; Yu M; Lin X; Wu M; Wang X; Lu H; Zhu S; Yu Y; Mao Z; Han W
Biomed Pharmacother; 2010 Sep; 64(7):482-6. PubMed ID: 20359857
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
11. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.
Sato N; Meijer L; Skaltsounis L; Greengard P; Brivanlou AH
Nat Med; 2004 Jan; 10(1):55-63. PubMed ID: 14702635
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.
Muralidharan S; Hanley PJ; Liu E; Chakraborty R; Bollard C; Shpall E; Rooney C; Savoldo B; Rodgers J; Dotti G
J Immunol; 2011 Nov; 187(10):5221-32. PubMed ID: 22013128
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19
Li J; Gao J; Zhou H; Zhou J; Deng Z; Lu Y; Rao J; Ji G; Gu J; Yang X; Xia Y; Wang X
Front Immunol; 2020; 11():603288. PubMed ID: 33343576
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
17. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
[TBL] [Abstract][Full Text] [Related]
18. Unrestrained glycogen synthase kinase-3 beta activity leads to activated T cell death and can be inhibited by natural adjuvant.
Sengupta S; Jayaraman P; Chilton PM; Casella CR; Mitchell TC
J Immunol; 2007 May; 178(10):6083-91. PubMed ID: 17475833
[TBL] [Abstract][Full Text] [Related]
19. GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
Liu K; Li J; Wu X; Chen M; Luo F; Li J
Int J Oncol; 2017 Dec; 51(6):1821-1830. PubMed ID: 29039496
[TBL] [Abstract][Full Text] [Related]
20. GSK3 inhibitors CHIR99021 and 6-bromoindirubin-3'-oxime inhibit microRNA maturation in mouse embryonic stem cells.
Wu Y; Liu F; Liu Y; Liu X; Ai Z; Guo Z; Zhang Y
Sci Rep; 2015 Mar; 5():8666. PubMed ID: 25727520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
